WednesdayMay 26, 2021 11:17 am

Researchers Identify Compound That Could Prevent Drug-Induced Arrhythmias

Some of the most commonly used medications, such as antibiotics, are usually administered in low doses, despite the greater therapeutic benefit they possess, because of the risk of arrhythmias. Arrhythmias occur when an individual’s heartbeat becomes irregular, beating either too slow or too fast. Cardiac arrhythmias usually occur when electrical impulses in an individual’s heart aren’t working properly. A team of researchers from various institutions have discovered a compound that hinders cardiac arrhythmias from occurring when these drugs are given in higher doses, through experimental and computational validation. This will make it easier for these drugs to be administered safely,…

Continue Reading

WednesdayMay 26, 2021 9:00 am

Cybin Inc. (NEO: CYBN) Files Patent Designed to Bolster IP Psychedelic Molecule, Delivery Mechanism Portfolio 

Company files 12th patent to strengthen proprietary IP program Cybin believes treatments can decrease costs, increase access to important therapeutics Patent provides wide range of benefits in Cybin’s four drug candidate program Cybin (NEO: CYBN) (OTCQB: CLXPF) has filed a new provisional patent application designed to strengthen the company’s ongoing drug candidate programs (https://ibn.fm/9V5sv). Cybin, a biotechnology company focused on progressing psychedelic therapeutics, is focused on expanding its four active drug programs targeting depression, addiction and other psychiatric conditions alongside its growing portfolio of 50+ proprietary psychedelic molecules. “By continuing to innovate in directions to enhance the patient experience and…

Continue Reading

TuesdayMay 25, 2021 1:08 pm

Case Study Shows Coronavirus Infection Can Trigger Recurrent Blood Clots

Rutgers Robert Wood Johnson Medical School researchers have discovered that the coronavirus may cause blood clots in an individual’s arms. Their findings, which were reported in the “Viruses” journal, delve into how inflammation brought about by the coronavirus can result in upper extremity blood clots. This case study is part of a bigger study by the institution involving a group of patients that had contracted the coronavirus infection and were either discharged or admitted to a hospital between March and May of last year. While researchers do know that the disease may cause lower extremity deep vein thrombosis, this is…

Continue Reading

TuesdayMay 25, 2021 10:30 am

GBM Brain Cancer Sorting Development Latest Bit of Good News for Patients as CNS Pharmaceuticals (NASDAQ: CNSP) Develops Drug Trial

Biopharmaceutical developer CNS Pharmaceuticals is working on ways to improve overall survivability for glioblastoma multiforme (“GBM”) brain cancer patients GBM is considered to be an incurable brain cancer that usually only leaves patients about 15 months to live once they are diagnosed, prompting research efforts to improve patients’ responses to therapeutic approaches A recent study found that the GBM patients most likely to succumb within a relatively short period could be identified with non-invasive MRI scans, allowing researchers to grant them priority in clinical trials Another recent study found patient responses could be improved simply by changing the time of…

Continue Reading

TuesdayMay 25, 2021 10:13 am

Brain Scientific Inc. (BRSF) May Provide Diagnostics Solutions for Sports Concussions as They Become Growing Public Health Problem

Sports concussions on the rise; with more children playing sports, it is becoming an important public health problem Quantitative EEG shows promise in identifying athletes with post-concussion impairments; for this, reusable EEG caps and mobile-based applications are helpful BRSF provides portable EEG devices that bring brain diagnostics to settings where it was previously impossible including off-site testing within sports A recent article published by Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company operating in the brain diagnostics space, discusses how concussions or Traumatic brain injuries (“TBI”) are a significant risk for young athletes, quickly becoming an important public health issue…

Continue Reading

MondayMay 24, 2021 1:51 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Upcoming Drug Candidate Trial Rides Swell of Groundbreaking Psychedelic Medicine Efforts

Tryp Therapeutics is a pharmaceutical company focused on developing new potential treatments for medical conditions with unmet needs The company’s current lead candidates for drug development are a synthetic psychedelic for treating fibromyalgia and eating disorders Tryp’s efforts to develop a psychedelic drug candidate are part of a broader scientific movement to use various mind-altering drugs to treat select neurological conditions when paired with the care of a trained therapist The company has been preparing to initiate a Phase 2a clinical trial for the psychedelic candidate in partnership with a medical research team at the University of Florida The idea…

Continue Reading

MondayMay 24, 2021 11:45 am

University of Washington Study Suggests Coronavirus Fatalities May Be Higher Than Official Reports Have Indicated

Researchers from the Institute for Health Metrics and Evaluation (“IHME”) at the University of Washington have discovered evidence suggesting that the number of individuals who have succumbed to the coronavirus is higher than official reports have indicated. The team performed an analysis on fatalities caused by the coronavirus and reported its findings on the IHME website. Many physicians involved in the fight against the pandemic agree that the number of individuals who have succumbed to this fatal disease is higher than official reports have shown. The discrepancy in numbers is mainly because many individuals who died weren’t listed as coronavirus…

Continue Reading

FridayMay 21, 2021 2:00 pm

Study Finds That Mental Health is Essential in Recovery from Cardiac Events

Recent research that was presented at the 70th Annual Scientific Session, which is held by the American College of Cardiology, has found that middle-aged and young adults who have been diagnosed with conditions such as anxiety or depression after they’ve suffered cardiac arrest have twice a higher chance of suffering from a second heart attack when compared with individuals who experience mild levels of distress. Researchers noted that the study evaluates how mental health impacts the outlook for cardiac arrest survivors. They added that they also tracked inflammatory markers that may contribute to an increased risk of cardiovascular diseases among…

Continue Reading

FridayMay 21, 2021 9:15 am

Brain Scientific Inc. (BRSF) Committed to Expand Access to Neurological Care for Infected Patients Amid the Pandemic

Consequences of novel Coronavirus infection on brain health are significant, requiring frequent brain monitoring Brain diagnostics in infected patients extremely limited due to their severe physical illnesses; traditional EEG time consuming, exposes frontline workers to virus transmission risk BRSF's sanitary disposable NeuroCap(TM) helps health care workers get quick, reliable insights into patient's condition while minimizing cross-contamination risk Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company providing next-gen solutions to the neurology market, is poised to offer a response to brain diagnostic challenges in the hospitals' red zones amid the pandemic. As the Company describes in one of the recent articles…

Continue Reading

ThursdayMay 20, 2021 1:00 pm

New Technique Promises to Deliver Cancer Drugs More Effectively

A University of Massachusetts team has created a nanoparticle that could potentially transform the way different diseases, including cancer, are treated. The approach combines two methods that allow medicine to be delivered to targeted cells more effectively. At the moment, one of the best new ways to deliver anti-cancer medicine is by using biologics (i.e., protein-based medications). The major benefits of this method are that the biologics have the capacity to replace proteins that have malfunctioned within a cell, and these drugs have minimal adverse side effects. The chief downside of biologics is that the particles are large, which limits…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050